These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27502738)

  • 1. Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database.
    Gilfrich C; Leicht H; Fahlenbrach C; Jeschke E; Popken G; Stolzenburg JU; Weißbach L; Zastrow C; Günster C
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):406-411. PubMed ID: 27502738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term Followup.
    Gilfrich C; May M; Fahlenbrach C; Günster C; Jeschke E; Popken G; Stolzenburg JU; Weissbach L; von Zastrow C; Leicht H
    J Urol; 2021 Mar; 205(3):855-863. PubMed ID: 33103943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser enucleation of the prostate versus transurethral resection of the prostate: perioperative outcomes from the ACS NSQIP database.
    Heidar NA; Labban M; Misrai V; Mailhac A; Tamim H; El-Hajj A
    World J Urol; 2020 Nov; 38(11):2891-2897. PubMed ID: 32036397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade?
    Eredics K; Wachabauer D; Röthlin F; Madersbacher S; Schauer I
    Urology; 2018 Aug; 118():152-157. PubMed ID: 29733869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy.
    Elkoushy MA; Elhilali MM
    Curr Urol Rep; 2016 Jun; 17(6):44. PubMed ID: 27048160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program.
    Bhojani N; Gandaglia G; Sood A; Rai A; Pucheril D; Chang SL; Karakiewicz PI; Menon M; Olugbade K; Ruhotina N; Sammon JD; Sukumar S; Sun M; Ghani KR; Schmid M; Varda B; Kibel AS; Zorn KC; Trinh QD
    J Endourol; 2014 Jul; 28(7):831-40. PubMed ID: 24517323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Outcomes of Transurethral Resection, Open Prostatectomy, and Laser Therapy in the Surgical Treatment of Benign Prostatic Obstruction: A "Real-World" Data Analysis from the URO-Cert Prostate Centers.
    Herden J; Ebert T; Schlager D; Pretzer J; Porres D; Schafhauser W; Kriegmair M; Schürmann MG; Distler F; Oberpenning F; Reimann M; Haupt G; Schmidt S; Laabs S; Planz B; Cohausz M; Gronau E; Platz G; Buse S; Jones J; Waldner M; Heidenreich A; Ruebben H; Zumbe J; Goell A; Khaljani E; Czempiel W; Schultze-Seemann W; Weib P
    Urol Int; 2021; 105(9-10):869-874. PubMed ID: 34289488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Patients Undergoing PVP Versus TURP for LUTS/BPH.
    Anderson BB; Pariser JJ; Helfand BT
    Curr Urol Rep; 2015 Aug; 16(8):55. PubMed ID: 26077354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
    Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
    BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery.
    Jaeger CD; Krambeck AE
    Urology; 2013 May; 81(5):1025-9. PubMed ID: 23465142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.
    Naspro R; Bachmann A; Gilling P; Kuntz R; Madersbacher S; Montorsi F; Reich O; Stief C; Vavassori I
    Eur Urol; 2009 Jun; 55(6):1345-57. PubMed ID: 19361906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes.
    Mayer EK; Kroeze SG; Chopra S; Bottle A; Patel A
    BJU Int; 2012 Dec; 110(11):1595-601. PubMed ID: 22540956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.
    Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
    Eur Urol; 2014 May; 65(5):931-42. PubMed ID: 24331152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time?
    Rieken M; Bachmann A; Shariat SF
    Curr Opin Urol; 2016 Jan; 26(1):22-7. PubMed ID: 26555691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.